MedTrace Logo

Telemedicine for Linkage to Care People Who Injected Drugs With Hepatitis C

NCT04035980 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2023-05-18

No results posted yet for this study

Summary

The investigators have designed a community-based intervention study to all subjects attended in drug addiction centers screened for hepatitis C virus (HCV) to evaluate the efficacy and acceptance of a telemedicine based programme versus conventional healthcare assistance

Conditions

  • Hepatitis C Virus Infection

Interventions

BEHAVIORAL

Telemedicine based healthcare programme

Two-way videoconference to evaluate the need of screening with DBS, disease stage evaluation and treatment of HCV RNA positive patients at drug addiction centers

Sponsors & Collaborators

  • University of La Laguna

    lead OTHER

Principal Investigators

  • Manuel Hernandez-Guerra, MD · MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-05
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04035980 on ClinicalTrials.gov